23 Nov Paul Ronksley
Bio
Paul Ronksley, PhD is an Associate Professor and health services researcher in the Department of Community Health Sciences, University of Calgary. He has a PhD in Epidemiology from the University of Calgary and completed a Post-doctoral Fellowship in Clinical Epidemiology at the Ottawa Hospital Research Institute. Dr. Ronksley has considerable experience in the use of administrative data to study health system use and outcomes in complex chronic disease patients. He also has a strong methodological skill set in the area of systematic reviews and meta-analysis. Dr. Ronksley is the Co-Director of the Alberta Kidney Disease Network (AKDN), a Co-investigator within the Interdisciplinary Chronic Disease Collaboration (ICDC) – a $6 million team grant funded through the CIHR SPOR Innovative Clinical Trials competition, and devotes 75% of his time to health research.
CNODES Projects
Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study
Site Investigator, AlbertaPrescription ranitidine use and population exposure in 6 Canadian provinces, 1996 to 2019: a serial cross-sectional analysis
Site Investigator, AlbertaSodium-glucose co-transporter-2 inhibitors and the risk of urosepsis: A multi-site, prevalent new-user cohort study
Site Investigator, AlbertaOff-label postpartum use of domperidone in Canada: a multidatabase cohort study
Site Investigator, AlbertaSodium-glucose cotransporter 2 inhibitors and the risk of below-knee amputation: a multicenter observational study
Site Investigator, AlbertaSodium-glucose cotransporter-2 inhibitors and the risk for diabetic ketoacidosis: a multicenter cohort study
Site Investigator, AlbertaCharacteristics of new users of newer antidiabetic drugs in Canada and the United Kingdom
Site Investigator, AlbertaValidity of an algorithm to identify cardiovascular deaths from administrative health records: a multi-database population-based cohort study
Collaborator, Alberta- Site Investigator, Alberta
Outpatient Nirmatrelvir-Ritonavir and Remdesivir Utilization in Canada
Site Investigator, AlbertaUse of Oral Fluoroquinolones in Canada: A Drug Utilization Study Update
Site Investigator, AlbertaLong-Acting Inhalable Drugs for Chronic Obstructive Pulmonary Disease
Site Investigator, Alberta